HB 796 -- LABELING OF DRUGS AND DEVICES SPONSOR: Hosmer COMMITTEE ACTION: Voted "do pass by consent" by the Committee on Children, Families and Health by a vote of 10 to 0. This bill revises a provision pertaining to the labeling of drugs and devices. The bill requires manufacturers, packers, distributors, and sellers of drugs and devices in Missouri to comply with the current federal labeling requirements contained in the Federal Food, Drug and Cosmetic Act and any federal regulations created under the act. Drugs and devices which contain labeling not in compliance with the bill will be deemed misbranded. The bill repeals the current state standards for considering a drug or device misbranded. FISCAL NOTE: No impact on state funds. PROPONENTS: Supporters say that drug manufacturers have to label drugs according to federal laws, not state law. Supporters also state that the bill would eliminate duplication between the federal and state laws on the labeling of drugs and devices. Testifying for the bill were Representative Hosmer; and Department of Health. OPPONENTS: There was no opposition voiced to the committee. Joseph Deering, Legislative AnalystCopyright (c) Missouri House of Representatives